Overweight
Conditions
Keywords
Increased non-specific inflammatory markers
Brief summary
Insoluble (1,3),(1,6)-beta-D-glucan from bakers yeast are indigestible polysaccharides. Previous studies indicate that the intake of insoluble dietary fiber is strongly associated with reduced risk of type 2 diabetes and cardiovascular disease. However, the mechanisms leading to this phenomenon are largely unknown. There are close relations between metabolic and inflammatory pathways, and a number of hormones, cytokines, signal proteins, bioactive lipids, and transcription factors have been shown to be involved in both systems. Beta-D-glucans have been suggested to play a role as so called biological response modifiers. Studies in animals indicate that even small doses of (1,3),(1,6)-beta-D-glucan may have beneficial effects on immune activity, i.e., by reducing the secretion of inflammatory factors. The investigators hypothesize that the intake of isolated (1,3), (1,6)-beta-D-glucan from bakers yeast improves inflammatory makers and insulin-sensitivity in overweight subjects with increased C-reactive protein concentrations at baseline.
Interventions
1,5 g Beta-D-Glucan daily
1.5 g waxy maize starch daily
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy subjects with normal glucose tolerance (NGT) * Impaired glucose tolerance (IGT) * Impaired fasting glucose (IFG)
Exclusion criteria
* Any severe cardiac disease * Liver * Kidney diseases * Type 1 or type 2 diabetes * Chronical and acute inflammatory diseases * Lipid lowering drugs * Cortisone * Antibiotics * Non-steroidal antiinflammatory drugs * Including low dose acetylsalicylic acid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Beta-D-glucan induced changes in inflammatory markers, adipokines, and gut hormones. Changes in insulin-sensitivity. | 3 days |
Secondary
| Measure | Time frame |
|---|---|
| Altered gene expression in adipose tissue if changes in primary outcome measures are shown. | 3 days |
Countries
Germany